Program Book - Confex

ACR/ARHP Poster Session B
1451. Elevation of Aldolase in Eosinophilic Fasciitis. Jennifer
Nashel 1 and Virginia D. Steen 2 , 1 Washington, DC,
2
Georgetown Univ Medical Center, Washington, DC
1452. HLA DQB1*03:02 Is a Marker for Severity of Interstitial
Lung Disease in Systemic Sclerosis. Shervin Assassi 1 ,
Filemon K. Tan 1 , Jun Ying 2 , Olga Y. Gorlova 2 , Brock E. Harper 3 ,
Hilda T. Draeger 4 , Emilio B. Gonzalez 3 , Rosa M. Estrada-Y-
Martin 1 , Julio Charles 1 , Xiaodong Zhou 1 , Frank C. Arnett 1 ,
John D. Reveille 1 and Maureen D. Mayes 1 , 1 University of
Texas Health Science Center at Houston, Houston, TX, 2 UT
M. D. Anderson Cancer Center, Houston, TX, 3 University of
Texas Medical Branch, Galveston, TX, 4 Univ of TX Health Sci
Ctr, San Antonio, TX
1453. Treatment of Idiopathic Retroperitoneal Fibrosis: A Single
Center Experience. Pietro Tartaro and Renzo Marcolongo,
Hematology and Clinical Immunology Unit, Padova, Italy
1454. Prevention of Digital Ulcers in Systemic Sclerosis
Patients: A Proposal of Risk Chart. Andreina Manfredi 1 ,
Marco Sebastiani 1 , Roberto D’Amico 1 , Valeria Carraro 2 ,
Mario Bocci 3 , Sheila Moscatelli 4 , Michele Iudici 5 , Michele
Colaci 1 , Dilia Giuggioli 1 and Clodoveo Ferri 6 , 1 University of
Modena and Reggio Emilia, Modena, Italy, 2 Rheumatology
Clinic, University of Padova, Padova, Italy, 3 Division of
Rheumatology, Catholic University of the Sacred Heart,
Rome, Italy, 4 University of Perugia, Perugia, Italy, 5 Second
University of Naples, Naples, Italy, 6 Rheumatology Unit,
University of Modena and Reggio Emilia, Modena, Italy
1455. Clinical Features of Gastrointestinal Involvement in
Patients with Systemic Sclerosis. Christiane Strohbeck 1 ,
Florian MP Meier 1 , Gabriela Riemekasten 2 , Christiane
Pfeiffer 3 , Andrea Himsel 4 , Ilka Herrgott 5 , Norbert Blank 6 ,
Jorg HW Distler 7 , Matthias Seidel 8 , Nicolas Hunzelmann 9
and Ulf Müller-Ladner 10 , 1 Justus-Liebig Universität Gießen,
Kerckhoff-Klinik GmbH, Bad Nauheim, Germany, 2 Charité
University Hospital, German Rheumatology Research Center,
a Leibniz Institute, Berlin, Germany, 3 University Hospital
Ulm, Ulm, Germany, 4 University Hospital Frankfurt, Frankfurt
am Main, Germany, 5 University Hospital Münster, Münster,
Germany, 6 University of Heidelberg, Eppelheim, Germany,
7
Department of Internal Medicine 3 and Institute for Clinical
Immunology, University of Erlangen-Nuremberg, Erlangen,
Germany, 8 University Hospital of Bonn, Bonn, Germany,
9
University of Cologne, Cologne, Germany, 10 Justus-Liebig-
University of Gießen, Bad Nauheim, Germany
1456. Trends in Mortality in Patients with Systemic Sclerosis
Over 40 Years: A Systematic Review and Meta-Analysis of
Case-Control and Cohort Studies. Muriel Elhai 1 , Christophe
Meune 2 , Jerome Avouac 1 , Andre Kahan 1 and Yannick
Allanore 1 , 1 Rheumatology A, Paris Descartes University,
Cochin Hospital, APHP, Paris, France, Paris, France, 2 Paris
Descartes University, Cardiology department, Cochin
Hospital, Paris, France
1457. Comparison of Wide Field Nailfold Capillaroscopy
and Videocapillaroscopy in the Assessment of the
Microcirculation in Patients with Raynaud‘s Phenomenon.
Juliana Sekiyama, Cintia Camargo, Luis Eduardo C. Andrade
and Cristiane Kayser, Universidade Federal de São Paulo, São
Paulo, Brazil
1458. Measuring Vascular Burden in Scleroderma and Raynaud
Phenomenon. Laura K. Hummers 1 , Stefan Zimmerman 1 ,
Fredrick M. Wigley 1 , John Carrino 1 , Erik Schwetje 2 , Warren
Greth 3 and Ami A. Shah 1 , 1 Johns Hopkins University,
Baltimore, MD, 2 MedImmune, LLC, Gaithersburg, MD,
3
MedImmune LLC, Gaithersburg, MD
1459. Watermelon Stomach in Systemic Sclerosis: A EUSTAR
Case-Control Study. Etienne Ghrenassia 1 , Jérôme Avouac 1 ,
Chris T. Derk 2 , Paolo Airo 3 , Dinesh Khanna 4 , Alice Berezne 5 ,
Kiet Tiev 6 , Francesca Ingegnoli 7 , Edoardo Rosato 8 , Paola
Caramaschi 9 , Roger Hesselstrand 10 , Valeria Riccieri 11 ,
Sharon Bae 12 , Virginia D. Steen 13 and Yannick Allanore 1 ,
1
Paris Descartes University, Rheumatology A department,
Cochin Hospital, Paris, France, 2 Jefferson Medical College,
Philadelphia, PA, 3 Brescia, Italy, 4 University of Michigan, Ann
Arbor, MI, 5 Paris Descartes University, Internal Medicine
department, Cochin Hospital, Paris, France, 6 Internal
Medicine Department, Saint Antoine Hospital, Paris,
France, 7 University of Milan, Milan, Italy, 8 Department
of Clinical Medicine, La Sapienza University, Rome, Italy,
9
Rheumatology Unit, Department of Medicine, Verona,
Italy, 10 Lund University & Skåne University Hopsital, Lund,
Sweden, 11 University of Rome, Medical Clinic and Therapy
Department, 12 Division of Rheumatology, Department
of Medicine, Geffen School of Medicine, University of
California at Los Angeles, Los Angeles, CA, 13 Georgetown
Univ Medical Center, Washington, DC
1460. Patient Reported Measures of Skin Activity Associate
with Disability in Diffuse Scleroderma. Julie J. Paik 1 , Laura
K. Hummers 1 , Fredrick M. Wigley 1 , Sharon R. Ghazarian 1 ,
Natalie R. Daya 1 , Ami A. Shah 1 and for the Imatinib Study
Group 2 , 1 Johns Hopkins University, Baltimore, MD, 2 CH-4002
Basel, Switzerland
1461. Identification of Mesenchymal Cells Expressing Endothelial
Markers in Small Pulmonary Arteries of Systemic
Sclerosis Associated Pulmonary Fibrosis: Possible Role of
Endothelial-Mesenchymal Transition. Fabian A. Mendoza 1 ,
Sonsoles Piera-Velazquez 1 , John L. Farber 2 and Sergio A.
Jimenez 1 , 1 Scleroderma Center and Jefferson Institute of
Molecular Medicine, Philadelphia, PA, 2 Department of
Pathology and Cell Biology Thomas Jefferson University,
Philadelphia, PA
1462. Outcomes of Systemic Sclerosis Associated Polyarthritis
Patients Treated by Biotherapies Tocilizumab or Abatacept:
A EUSTAR Observational Study. Marine Meunier 1 , Marco
Matucci Cerinic 2 , Britta Maurer 3 , Gabriela Riemekasten 4 ,
Raffaele Pellerito 5 , Carlos Alberto von Mühlen 6 , Alessandra
Vacca 7 , Paolo Airo 8 , Francesca Bartoli 2 , Ginevra Fiori 2 , Oliver
240
2011 Program Book